SBIX holdings
As of , SBIX (Invesco NASDAQ Biotech UCITS ETF, ISIN IE00BQ70R696) has 244 holdings on our record, together 100.0% of the fund; the ten largest make up 45.4%. Weights are shares of the whole fund.
Largest holdings
| Rank# | Holding | Weight as a percentage of the fund |
|---|---|---|
| 1 | Gilead Sciences | 8.16% |
| 2 | Amgen | 7.85% |
| 3 | Vertex Pharmaceuticals | 7.69% |
| 4 | Moderna | 5.04% |
| 5 | Regeneron PharmaceuticalsREGN | 5.03% |
| 6 | Revolution Medicines | 2.88% |
| 7 | Illumina | 2.71% |
| 8 | Biogen | 2.19% |
| 9 | Alnylam Pharmaceuticals | 2.16% |
| 10 | Roivant Sciences | 1.73% |
Source: Invesco, holdings as published, as of
All holdings
The fund publishes 244 holdings; the ten largest make up 45.4% of it.
Create a free account to see the full holdings list
Sign-up takes an email address. There is no card to enter and nothing to pay.
Where it invests
The whole portfolio by sector, country and type of asset, every line, as a share of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.
By sector
- Information Technology34.4%
- Health Care15.0%
- Financials13.2%
- Consumer Discretionary12.9%
- Industrials9.1%
- Communication Services5.5%
- Materials3.2%
- Energy2.8%
- Consumer Staples1.9%
- Real Estate1.2%
- Utilities0.8%
By country
- United States87.6%
- Switzerland5.6%
- South Korea1.3%
- Netherlands1.1%
- Mexico1.0%
- Brazil0.9%
- Sweden0.9%
- Israel0.4%
- Germany0.3%
- Taiwan0.3%
- Costa Rica0.2%
- Finland0.2%
- Norway0.1%
More:SBIX: key facts, returns and chargesCompare what it holds with another fundHoldings overlapHow overlap is measured
Holdings and weights are as published by Invesco on 30/09/2026 and change as the fund trades.